Isabelle Staropoli

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

40h-index10.1kcitations105works21.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(61), COVID-19 Clinical Research Studies(38), SARS-CoV-2 detection and testing(30), HIV Research and Treatment(19), Immune Cell Function and Interaction(11)

Publications105 total

Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern France
Scientific Reports·2025Open Access
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study
Intensive Care Medicine Experimental·2025Open Access
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivo
Nature Communications·2025Open Access
Immunogenicity of single-chain antibodies: germlining of a VHH lowers T-cell activation from epitopes in FR2 and CDR regions
mAbs·2025· 1 citedOpen Access
Epitope-Driven Polyfunctional Divergence of SARS-CoV-2 RBD Antibodies
2025Open Access
Intranasal delivery of a broadly neutralizing single domain antibody targeting ACE2 protects against SARS-CoV-2 infection
2024Open Access
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Pathogens and Immunity·2024· 42 citedOpen Access
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting
The Journal of Experimental Medicine·2024· 23 citedOpen Access
Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
2024· 4 citedOpen Access
In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients
Transplant International·2024· 1 citedOpen Access
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
iScience·2024· 11 citedOpen Access
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
Nature Communications·2024· 215 citedOpen Access
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
Heliyon·2024· 1 citedOpen Access
Recapitulating memory B cell responses in a Lymphoid Organ-Chip to evaluate mRNA vaccine boosting strategies
2024· 2 citedOpen Access
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
Journal of Virology·2023· 9 citedOpen Access
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
2023· 39 citedOpen Access
Neutralizing Antibody Levels as a Correlate of Protection Against <scp>SARS‐CoV</scp>‐2 Infection: A Modeling Analysis
Clinical Pharmacology & Therapeutics·2023· 9 citedOpen Access
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients
Med·2023· 15 citedOpen Access
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
2023· 1 citedOpen Access
Divergent adaptive immune responses define two types of long COVID
Frontiers in Immunology·2023· 26 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Olivier Schwartz(31), Timothée Bruel(27), Delphine Planas(19), Cyril Planchais(19), Hugo Mouquet(18), Ludivine Grzelak(18), Florence Guivel‐Benhassine(16), Françoise Porrot(16), Laurent Hocqueloux(14), Thiérry Prazuck(14), Etienne Simon‐Lorière(14), David Veyer(13), Hélène Péré(13), Julian Buchrieser(13), Matthieu Prot(12), Arnaud Fontanet(12), Fernando Arenzana‐Seisdedos(11), Aymeric Sève(10), Laura Tondeur(10), Bruno Hoen(10)